Scalp psoriasis
- PMID: 20715392
Scalp psoriasis
Abstract
Psoriasis is a chronic, debilitating disease that commonly involves the scalp. Despite a wide range of therapy options, scalp psoriasis remains difficult to treat, highlighting a long-standing unmet need for the safe and effective treatment of scalp psoriasis. Many topical therapies for scalp psoriasis are also difficult or unpleasant to apply, resulting in decreased adherence and efficacy. In brief, the high level of patient dissatisfaction with currently available treatments for psoriasis supports the need for new, effective and well-tolerated treatment options for scalp psoriasis. This article aims to review the efficacy and safety of new formulations and treatment options available to control scalp psoriasis. For example, a new formulation of calcipotriene/betamethasone scalp solution has a rapid onset of action with once daily dosing that improves compliance. The CalePso study examines the safety profile of otherwise established Clobetasol propionate (CP) shampoo 0.05%, and reports that CP shampoo is safe and efficacious in the long-term management of scalp psoriasis. A new foam formulation of coal tar is shown to be cosmetically acceptable and easier to apply.
Similar articles
-
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.Br J Dermatol. 2009 Jul;161(1):159-66. doi: 10.1111/j.1365-2133.2009.09116.x. Epub 2009 Mar 26. Br J Dermatol. 2009. PMID: 19416259 Clinical Trial.
-
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.Br J Dermatol. 2009 Jan;160(1):170-6. doi: 10.1111/j.1365-2133.2008.08927.x. Epub 2008 Nov 25. Br J Dermatol. 2009. PMID: 19067709 Clinical Trial.
-
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.J Dermatolog Treat. 2005 Feb;16(1):31-6. doi: 10.1080/09546630410024853. J Dermatolog Treat. 2005. PMID: 15897165 Clinical Trial.
-
Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S39-49. doi: 10.1016/j.jaad.2005.04.029. J Am Acad Dermatol. 2005. PMID: 15968263 Review.
-
Scalp psoriasis: a review of current topical treatment options.J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1151-60. doi: 10.1111/j.1468-3083.2007.02424.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17894698 Review.
Cited by
-
[Psoriasis capitis and seborrhoic eczema of scalp diseases].Hautarzt. 2017 Jun;68(6):457-465. doi: 10.1007/s00105-017-3986-4. Hautarzt. 2017. PMID: 28567508 Review. German.
-
Shampoo and Conditioners: What a Dermatologist Should Know?Indian J Dermatol. 2015 May-Jun;60(3):248-54. doi: 10.4103/0019-5154.156355. Indian J Dermatol. 2015. PMID: 26120149 Free PMC article. Review.
-
Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis.J Clin Aesthet Dermatol. 2016 Jun;9(6 Suppl 1):S12-S16. Epub 2016 Jun 1. J Clin Aesthet Dermatol. 2016. PMID: 28439342 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous